Indication
SARS
7 clinical trials
24 products
6 drugs
Clinical trial
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Proof of Concept Study of LSALT Peptide as Prevention of Acute Respiratory Distress Syndrome (ARDS) and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)Status: Completed, Estimated PCD: 2021-05-27
Product
PlaceboProduct
LSALTProduct
LSALT peptideClinical trial
COVID-19: A Phase 1, Partially Blind, Placebo-controlled, Dose Escalation, First-in-human, Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity After 1 and 2 Doses of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV Administered Intramuscularly in Healthy AdultsStatus: Completed, Estimated PCD: 2021-12-21
Product
CVnCoVClinical trial
COVID-19: A Phase 3, Randomized, Observer-Blinded, Placebo-Controlled Clinical Study Evaluating the Safety and Immunogenicity of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adult Health Care Workers in Mainz (Germany)Status: Completed, Estimated PCD: 2022-06-08
Clinical trial
COVID-19: A Phase 2a, Partially Observer-blind, Multicenter, Controlled, Dose-confirmation Clinical Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults >60 Years of Age and 18 to 60 Years of AgeStatus: Completed, Estimated PCD: 2022-02-21
Product
Pneumococcal vaccineProduct
Hepatitis A vaccineClinical trial
Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized TrialStatus: Completed, Estimated PCD: 2022-12-30
Product
ColchicineProduct
Interferon-BetaDrug
AspirinDrug
RivaroxabanClinical trial
First-in-human Trial of the Coronavirus Virus-like Particle Subunit Vaccine ABNCoV2 in SARS-CoV-2-naïve Adult Volunteers in Good HealthStatus: Completed, Estimated PCD: 2021-12-30
Product
ABNCoV2Clinical trial
Randomised Evaluation of COVID-19 TherapyStatus: Recruiting, Estimated PCD: 2026-06-30
Product
Lopinavir-RitonavirProduct
CorticosteroidProduct
HydroxychloroquineProduct
AzithromycinProduct
Convalescent plasmaDrug
TocilizumabDrug
TafasitamabDrug
JAKiProduct
AnakinraProduct
Dimethyl fumarateProduct
High Dose CorticosteroidProduct
EmpagliflozinProduct
SotrovimabProduct
MolnupiravirProduct
Baloxavir MarboxilProduct
OseltamivirProduct
Dexamethasone